These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8409470)

  • 1. A modified method for obtaining large amounts of high titer polyclonal ascites fluid.
    Ou SK; Hwang JM; Patterson PH
    J Immunol Methods; 1993 Sep; 165(1):75-80. PubMed ID: 8409470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of large amounts of mouse polyclonal antisera.
    Kurpisz M; Gupta SK; Fulgham DL; Alexander NJ
    J Immunol Methods; 1988 Dec; 115(2):195-8. PubMed ID: 3198923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A modified method to induce immune polyclonal ascites fluid in BALB/c mice using Sp2/0-Ag14 cells.
    Lacy MJ; Voss EW
    J Immunol Methods; 1986 Mar; 87(2):169-77. PubMed ID: 3950427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anticomplement activity of the serum, ascitic fluid and tumor fluid of animals with transplantable experimental neoplasms. Cytotoxic activity of the antibodies].
    Valguarnera G
    Boll Soc Ital Biol Sper; 1974 Aug; 50(13):1013-6. PubMed ID: 4463978
    [No Abstract]   [Full Text] [Related]  

  • 5. Production of polyclonal antibodies in ascitic fluid of mice: technique and applications.
    Overkamp D; Mohammed-Ali S; Cartledge C; Landon J
    J Immunoassay; 1988; 9(1):51-68. PubMed ID: 3283169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dialysis-based bioreactor systems for the production of monoclonal antibodies--alternatives to ascites production in mice.
    Bruce MP; Boyd V; Duch C; White JR
    J Immunol Methods; 2002 Jun; 264(1-2):59-68. PubMed ID: 12191510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunoregulatory effects of ascites of tumor-bearing mice].
    Jia FL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1988 Dec; 10(6):426-9. PubMed ID: 2978399
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of sarcoma 180 TG cells for obtaining ascitic fluid from mice hyperimmune to the foot-and-mouth disease virus].
    Piccone ME; Marcovecchio F; Arese A; Zuloaga G
    Rev Argent Microbiol; 1989; 21(2):75-8. PubMed ID: 2559425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using a tropism-modified adenoviral vector to circumvent inhibitory factors in ascites fluid.
    Blackwell JL; Li H; Gomez-Navarro J; Dmitriev I; Krasnykh V; Richter CA; Shaw DR; Alvarez RD; Curiel DT; Strong TV
    Hum Gene Ther; 2000 Aug; 11(12):1657-69. PubMed ID: 10954900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved efficiency of hybridoma ascites production by intrasplenic inoculation in mice.
    Witte PL; Ber R
    J Natl Cancer Inst; 1983 Mar; 70(3):575-7. PubMed ID: 6339777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient production of large volumes of immune ascitic fluid from mice.
    Deig EF
    Arch Gesamte Virusforsch; 1974; 45(1-2):155-6. PubMed ID: 4413191
    [No Abstract]   [Full Text] [Related]  

  • 12. A method for producing anti-DNA antibodies in ascitic fluid of mice.
    Kitagawa Y; Okuhara E
    J Immunol Methods; 1976 Mar; 10(2-3):151-9. PubMed ID: 932438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of Salmonella H antibodies in mouse ascites fluid.
    Bettelheim KA; Maskill WJ
    Comp Immunol Microbiol Infect Dis; 1992 Apr; 15(2):125-9. PubMed ID: 1563259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of the fifth component of murine complement from ascites fluid.
    Lin RH; Stockinger B
    J Immunol Methods; 1988 Nov; 115(1):127-31. PubMed ID: 3192942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of human ovarian tumor-associated antigens by antibodies isolated from ovarian carcinoma ascitic fluid.
    Rao GS; Hanjani P
    Am J Obstet Gynecol; 1988 Jul; 159(1):94-8. PubMed ID: 3394756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of large amounts of antibodies in individual mice.
    Tung AS; Ju ST; Sato S; Nisonoff A
    J Immunol; 1976 Mar; 116(3):676-81. PubMed ID: 1254948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of approaches for augmenting the serologic response to the individually specific methylcholanthrene-induced sarcoma-Meth A: pretreatment with cyclophosphamide is most effective.
    Livingston PO; DeLeo AB; Jones M; Oettgen HF
    J Immunol; 1983 Nov; 131(5):2601-5. PubMed ID: 6631013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of moderate amounts of polyclonal antibodies in mice.
    Luo W; Lin SH
    Biotechniques; 1997 Oct; 23(4):630-2. PubMed ID: 9343678
    [No Abstract]   [Full Text] [Related]  

  • 19. Alternatives to pristane priming for ascitic fluid and monoclonal antibody production.
    Gillette RW
    J Immunol Methods; 1987 May; 99(1):21-3. PubMed ID: 3571991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of solubilized tumor antigen extracted from P1798 murine lymphoma cells or isolated from tumor-bearer ascites fluid and reactivity with anti-thy-1.2 antiserum.
    Gordon WC; Baechtel FS; Goetz G; Prager MD
    Int J Cancer; 1977 May; 19(5):692-9. PubMed ID: 68017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.